Literature DB >> 34980794

Adult T Cell Leukemia/Lymphoma Becoming Apparent during Treatment of Pulmonary Abscess and Empyema Caused by Nocardia asiatica: A Case Report and Review of the Literature.

Yusuke Hayashi1, Takamasa Kitajima1, Satoshi Marumo1, Motonari Fukui1.   

Abstract

Nocardia is a Gram-positive bacterium that causes opportunistic infections. Nocardia asiatica was newly isolated in 2004, and there have been no case reports describing the empyema caused by N. asiatica. Adult T-cell leukemia/lymphoma (ATL) is a peripheral T-cell malignancy caused by human T-cell leukemia virus type 1 (HTLV-1). We herein report a case in which immunosuppression attributable to ATL may have led to pulmonary abscess and empyema caused by N. asiatica. Our case demonstrates the need to investigate causes of immunosuppression, including ATL, in patients showing nocardiosis.

Entities:  

Keywords:  Nocardia asiatica; adult T-cell leukemia/lymphoma; human T-cell leukemia virus; nocardiosis

Mesh:

Year:  2021        PMID: 34980794      PMCID: PMC9381332          DOI: 10.2169/internalmedicine.8428-21

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.282


Introduction

Nocardiosis is an uncommon disease caused by aerobic Gram-positive bacteria in the genus Nocardia, which are usually found in soils, water, or air. The genus Nocardia is composed of 13 medically important species, of which N. asteroides, N. farcina, N. nova, and N. abscessus cause the majority of invasive infections (1). Nocardia asiatica was newly isolated by Kageyama et al. from three N. asteroides-like strains obtained in Japan and Thailand in 2004 (2). To date, only a few case reports have described N. asiatica infections, and details of the nocardiosis caused by this strain are unclear. Nocardia species can cause localized or systemic suppurative diseases in humans and animals. The lung is the major target organ involved in Nocardia infections because the main portal of entry is inhalation (3). The main risk factor for nocardiosis is immunosuppression, such as that induced by prolonged corticosteroid therapy, malignancy, organ transplantation, or human immunodeficiency virus infection. Human T-cell leukemia virus type 1 (HTLV-1) was identified as the first human oncogenic retrovirus 30 years ago (4). In southern Japan, the prevalence of HTLV-1 in the general population is more than 10%, making it the area with the highest HTLV-1 prevalence worldwide (5). Adult T-cell leukemia/lymphoma (ATL) is a peripheral T-cell malignancy caused by HTLV-1 that is characterized by clonal proliferation of CD4-positive T cells containing randomly integrated HTLV-1 provirus (6). Patients with ATL are often immunosuppressed and are at risk of developing opportunistic infections (5). We herein report a case showing pulmonary abscesses and empyema caused by N. asiatica under ATL-induced immunosuppression. In addition, we provide a review of the literature on N. asiatica cases.

Case Report

A 78-year-old Japanese man visited a hospital with general malaise in March 2020. Chest computed tomography (CT) showed massive and multilocular left pleural effusion. He was suspected of having empyema and was admitted to our hospital. His medical history included bladder cancer (cTaN0M0, cStage 0a) and prostate cancer (cT4N1M1b, cStage IV). He had no history of pulmonary disease or drug abuse. He had smoked approximately 25 cigarettes a day for 58 years until admission. He had been previously employed as an electric mechanic. He had been born in Nagasaki Prefecture, located on the northwest side of Kyushu, southwest of the four major Japanese islands. His family history included no remarkable disease-related findings. A physical examination revealed multiple untreated dental caries and stumps but no skin lesions. His vital signs were as follows: body temperature, 38.1 °C; heart rate, 92 beats/min; respiratory rate, 25 breaths/min; blood pressure, 179/100 mmHg; and oxygen saturation, 85% on room air. Auscultation of his left lung revealed decreased breath sounds. The main results of the laboratory examinations are shown in Table 1. His white blood cell count was 13,700 /μL, and his C-reactive protein level was 36.9 mg/dL. Chest radiography and CT showed large and multilocular left pleural effusions with a rightward shift of the mediastinum and trachea (Fig. 1, 2).
Table 1.

Main Laboratory Results on Admission.

Hematology
White blood cells13,700/µL
Neutrophil count83.8%
Lymphocyte count14.4%
Atypical lymphocyte count0.5%
Red blood cells276×104/µL
Hemoglobin8.6 g/dL
Platelets43.8×104/µL
Blood chemistry
Aspartate aminotransferase37U/L
Alanine aminotransferase14U/L
Lactate dehydrogenase277U/L
Alkaline phosphatase287U/L
γ-Glutamyltranspeptidase30U/L
Albumin3.9g/dL
Blood urea nitrogen60.7mg/dL
Creatinine2.08mg/dL
C-reactive protein36.9mg/dL
Infection
T-SPOT®-
HIV Ag/Ab0.06S/CO
HTLV-1,2107.72S/CO
Tumor marker
PSA0.317ng/mL
sIL2-R6,005U/mL

HIV: human immunodeficiency virus, HTLV: human t-cell leukemia virus, PSA: prostate specific antigen, sIL2-R: soluble interleukin-2 receptor

Figure 1.

Time course of chest radiography findings showed the improvement of empyema. (A) On admission, (B) after insertion of two chest drainage tubes, and (C) at the time of discharge.

Figure 2.

Time course of chest computed tomography findings showed the improvement of pulmonary abscess and empyema. (A, B) On admission, (C, D) day 6, and (E, F) day 50.

Main Laboratory Results on Admission. HIV: human immunodeficiency virus, HTLV: human t-cell leukemia virus, PSA: prostate specific antigen, sIL2-R: soluble interleukin-2 receptor Time course of chest radiography findings showed the improvement of empyema. (A) On admission, (B) after insertion of two chest drainage tubes, and (C) at the time of discharge. Time course of chest computed tomography findings showed the improvement of pulmonary abscess and empyema. (A, B) On admission, (C, D) day 6, and (E, F) day 50. We inserted two chest drainage tubes: one in the left upper chest and the other in the lower chest. He was diagnosed with empyema due to purulent drainage. Laboratory results for the pleural effusions are shown in Table 2. Gram staining and Kinyoun's acid-fast staining from pleural effusions were performed, but both showed negative results. We administered ampicillin/sulbactam (ABPC/SBT) and intrathoracic lavage with saline and intracavitary instillation of urokinase through both chest tubes several times, promoting drainage of pus. On day 7, cultures from pleural effusions were grown, and N. asiatica was identified using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF-MS). An in vitro drug susceptibility analysis could not be performed because of the small number of colonies.
Table 2.

The Examination Results of Pleural Effusions.

pH7.5
White blood cell2,200/µL
Neutrophil count68.1%
Albumin2.6g/dL
Glucose72mg/dL
Lactate dehydrogenase1,283IU/L
CEA5.9ng/mL
Hyaluronic acid44,000ng/mL
ADA60.7

ADA: adenosine deaminase, CEA: carcinoembryonic antigen

The Examination Results of Pleural Effusions. ADA: adenosine deaminase, CEA: carcinoembryonic antigen Trimethoprim-sulfamethoxazole (TMP-SMX) was added to the treatment regimen. Two sets of blood cultures were negative, and there were no lesions in the central nervous system on brain magnetic resonance imaging (MRI). On day 13, N. asiatica was cultured again from follow-up pleural effusions, so we changed the antibiotics from ABPC/SBT to minocycline (MINO) and imipenem/cilastatin (IPM/CS) in addition to TMP-SMX. Laboratory examinations revealed that the proportion of atypical lymphocytes (“flower cells”) among white blood cells had increased from 0.5% (day 1) to 30.3% (day 15). Antibodies against HTLV-1 were detected in the serum using an enzyme-linked immunosorbent assay (ELISA). Biclonal bands for HTLV-1 provirus DNA were observed in peripheral blood specimens by a Southern blot hybridization analysis (Fig. 3).
Figure 3.

Southern blot analysis of HTLV-1 provirus DNA depicted two bands (black arrows) after EcoR I digestion and two bands (black arrows) after Pst I digestion indicating biclonality of HTLV-1. M: size marker, 1: positive control, 2: negative control, 3: this patient, E: EcoR I (restriction enzyme), P: Pst I (restriction enzyme)

Southern blot analysis of HTLV-1 provirus DNA depicted two bands (black arrows) after EcoR I digestion and two bands (black arrows) after Pst I digestion indicating biclonality of HTLV-1. M: size marker, 1: positive control, 2: negative control, 3: this patient, E: EcoR I (restriction enzyme), P: Pst I (restriction enzyme) Although the proportion of atypical lymphocytes increased rapidly at first, lymphocytosis stabilized thereafter. A cytological assessment of the pleural effusions showed no atypical lymphocytes. Body CT and brain MRI did not reveal any organ involvement. Based on these findings, we diagnosed the patient with chronic-type ATL with no unfavorable prognostic factors, such as a low serum albumin level, high lactate dehydrogenase level, or high urea nitrogen concentration. Therefore, we decided to follow-up the ATL without active treatment. Drug-induced kidney dysfunction was detected after the onset of TMP-SMX treatment; therefore, the patient was treated with a combination of MINO and amoxicillin/clavulanate (AMPC/CVA). After chest CT, the empyema improved, and his left lung expanded again. There were three cavitary nodules in his re-expanded left lung, indicating the presence of pulmonary abscesses in addition to empyema (Fig. 2). Two chest drainage tubes were removed on days 3 and 15, respectively. His condition gradually improved, resulting in the disappearance of his fever and malaise and a reduction in the serum C-reactive protein (CRP) level. Since the prolonged treatment deteriorated his activities of daily living (ADL), he was transferred to another hospital for rehabilitation.

Discussion

The specific feature of the present case was the presence of pulmonary abscess and empyema caused by N. asiatica, and the concomitant occurrence of ATL during the treatment of nocardiosis. In this case, although Gram staining and Kinyoun's acid-fast staining from pleural effusions both showed negative findings, we identified N. asiatica using colonies cultured from pleural effusions by MALDI-TOF-MS. The genus Nocardia includes more than 80 species, of which at least 33 cause diseases in humans (7,8). Determination of the Nocardia species causing an infection is important because different species vary in their epidemiology, virulence, and antibiotic susceptibility. Traditional methods for the determination of Nocardia species include biochemical tests and susceptibility profiling, but the identification of Nocardia species in such tests is often difficult. To overcome these limitations, sequencing methods, such as 16S ribosomal ribonucleic acid (16S rRNA) gene sequencing, have been advocated for Nocardia species identification, but they remain unavailable in clinical practice. Recently, MALDI-TOF-MS, which can analyze the protein composition of a bacterial cell, has been identified as a rapid and accurate method for the identification of Nocardia species in clinical laboratories (9,10). N. asiatica is a rare Nocardia species that was newly identified in 2004. There are few reports describing N. asiatica infections, including respiratory infections such as pneumonia and mediastinal infections (11,12). We conducted a systematic review of relevant articles in the Medline database using the term “Nocardia asiatica.” We identified a total of 24 articles, including 15 case reports of N. asiatica infections (Table 3). Non-English articles were excluded from this study. With the increasing popularity of MALDI-TOF-MS, N. asiatica may be detected as a causative pathogen more frequently, as in this case.
Table 3.

Literature Review of N. asiatica Infections.

Case no./referenceAge/sexSite(s) of infectionUnderlying disease(s)Diagnostic method(s)Treatment(s)Outcome
1/(20)45/MSkinHIV16S rRNATMP-SMXRecovered
2/(21)57/FLungAsthma16S rRNATMP-SMX MEPM AMK LZDRecovered
3/(22)60/MLungDM16S rRNATMP-SMX MEPM OperationRecovered
4/(23)49/MMediastinalMGUnknownIPM AMK TMP-SMXRecovered
5/(24)66/MLungAIP16S rRNAAMK IPM AMPC/CVA MINORecovered
6/(25)66/MElbowNone16S rRNALZDRecovered
7/(11)64/FLungOld Tb16S rRNATMP-SMXRecovered
8/(26)76/MLungAAV Old Tb16S rRNATMP-SMX DRPMRecovered
9/(27)65/MBrain LungAIHA16S rRNATMP-SMXRecovered
10/(28)51/MBrainSLE16S rRNATMP-SMX CTRX MINO AMPC/CVADied
11/(29)37/MDisseminatedHIV16S rRNAMEPM AMK TMP-SMXRecovered
12/(12)40/FBrain MediastinalHIV16S rRNATMP-SMX CTRX AMK OperationRecovered
13/(30)53/MBrainHIVMALDI-TOF-MS 16S rRNATMP-SMXRecovered
14/(31)61/FBrainMalignancy DMMetagenomics next-generation sequencingLinezolid TMP-SMX OperationRecovered
15/(32)33/MSkinNoneBacterial cultureAMKRecovered
16/Our case78/MLungATL MalignancyMALDI-TOF-MSTMP-SMX MINO IPM/CS AMPC/CVARecovered

AAV: antineutrophil cytoplasmic antibody associated vasculitis, AIHA: autoimmune hemolytic anemia, AIP: autoimmune pancreatitis, AMK: amikacin, AMPC/CVA: amoxicillin/clavulanate, ATL: adult T-cell leukemia/lymphoma, CTRX: ceftriaxone, DM: diabetes mellitus, DRPM: dripenem, HIV: human immunodeficiency virus, IPM/CS: imipenem/cilastatin, LZD: linezolid, MALDI-TOF-MS: matrix-assisted laser desorption ionization-time of flight mass spectrometry, MEPM: meropenem, MG: myasthenia gravis, MINO: minocycline, Tb: tuberculosis, TMP-SMX: trimethoprim-sulfamethoxazole, 16S rRNA: 16S ribosomal ribonucleic acid

Literature Review of N. asiatica Infections. AAV: antineutrophil cytoplasmic antibody associated vasculitis, AIHA: autoimmune hemolytic anemia, AIP: autoimmune pancreatitis, AMK: amikacin, AMPC/CVA: amoxicillin/clavulanate, ATL: adult T-cell leukemia/lymphoma, CTRX: ceftriaxone, DM: diabetes mellitus, DRPM: dripenem, HIV: human immunodeficiency virus, IPM/CS: imipenem/cilastatin, LZD: linezolid, MALDI-TOF-MS: matrix-assisted laser desorption ionization-time of flight mass spectrometry, MEPM: meropenem, MG: myasthenia gravis, MINO: minocycline, Tb: tuberculosis, TMP-SMX: trimethoprim-sulfamethoxazole, 16S rRNA: 16S ribosomal ribonucleic acid Because N. asiatica is a rare species, the most appropriate therapeutic agent, administration route, and treatment duration have not been well established. In general, several drug regimens based on TMP-SMX as a key drug are recommended as first-line therapy for some cases of severe pulmonary nocardiosis (13). Susceptibility tests for all clinically significant Nocardia isolates are recommended because antimicrobial susceptibility patterns vary among different studies, countries, and Nocardia species. Unfortunately, we were unable to perform a susceptibility test; therefore, based on our literature review, we empirically treated the patient with TMP-SMX, MINO, IMP/CS, and AMPC/CVA. Although we were unable to continue TMP-SMX in this patient due to renal dysfunction, treatment with MINO and AMPC/CVA was successful. Determining the optimal treatment regimen for N. asiatica infections will require further study. One review showed that 64% of 1,050 patients with nocardiosis were immunocompromised (14). The most common causes of immunosuppression were glucocorticoid therapy, malignancy, organ and hematopoietic stem cell transplantation, and HIV infection. In the present case, the patient had bladder cancer (cTaN0M0, cStage 0a) and prostate cancer (cT4N1M1b, cStage IV). Although these cancers may have been responsible for the nocardiosis, both cancers were stable. Furthermore, he was only administered goserelin acetate, which is a hormonal drug, for prostate cancer and had never been treated with chemotherapy. Initially, we were unable to recognize his immunosuppressive status which induced empyema caused by Nocardia except for malignancy. Since the numbers of atypical lymphocytes were rapidly increased in his peripheral blood after admission, we were able to detect the presence of ATL during the treatment of empyema. ATL is a peripheral T-cell malignancy caused by HTLV-1, an oncogenic human RNA retrovirus (15). Southwestern Japan is one of the most endemic areas for its associated malignancy, along with the Caribbean basin, Central and South America, and Western Africa (16). The patient was born in Nagasaki Prefecture on the northwest side of Kyusyu, in southwestern Japan. The frequency of opportunistic infections among HTLV-1 carriers and ATL patients is 1.5% and 6.5%, respectively. The pathogenic microorganisms are diverse, including Cryptococcus, Aspergillus, Pneumocystis, and Cytomegalovirus (17). Although the mechanisms underlying immunosuppression in ATL patients remain obscure, a reduced CD4-positive T-cell function due to HTLV-1 infection has been proposed to be a causative mechanism (18,19). Aggressive chemotherapy may be required to kill HTLV-1-infected CD4-positive T cells, but this increases the risk of further immunosuppression and opportunistic infections. We were unable to administer treatment for ATL to this patient, since his ADL declined during the treatment of nocardiosis. In conclusion, we encountered a rare case of ATL that became apparent during the treatment of pulmonary abscess and empyema due to N. asiatica. Clinicians should consider the potential of N. asiatica to cause pulmonary infections, including empyema, and at the diagnosis of nocardiosis, they should investigate the possibility of disease-producing immunosuppression, including ATL, as in this case. The authors state that they have no Conflict of Interest (COI).
  32 in total

1.  Rapid and accurate diagnosis of brain abscess caused by Nocardia asiatica with a combination of Ziehl-Neelsen staining and metagenomics next-generation sequencing.

Authors:  T Huang; Y Chen; J Zhang; R He; D Qu; Q Ye; X Chen
Journal:  Eur J Neurol       Date:  2021-01       Impact factor: 6.089

Review 2.  Human T-lymphotropic virus 1: recent knowledge about an ancient infection.

Authors:  Kristien Verdonck; Elsa González; Sonia Van Dooren; Anne-Mieke Vandamme; Guido Vanham; Eduardo Gotuzzo
Journal:  Lancet Infect Dis       Date:  2007-04       Impact factor: 25.071

3.  Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nocardia species.

Authors:  A Verroken; M Janssens; C Berhin; P Bogaerts; T-D Huang; G Wauters; Y Glupczynski
Journal:  J Clin Microbiol       Date:  2010-09-22       Impact factor: 5.948

4.  Endobronchial hamartoma with obstructive pneumonia due to Nocardia asiatica.

Authors:  Takako Matsumoto; Toshihide Shimizu; Yukie Aoshima; Hideaki Oda; Ken Kikuchi; Hideki Katsura; Tomoko Fujiwara; Takamasa Onuki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-02-10

Review 5.  Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy.

Authors:  Barbara A Brown-Elliott; June M Brown; Patricia S Conville; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

6.  Phylogeny of the genus Nocardia based on reassessed 16S rRNA gene sequences reveals underspeciation and division of strains classified as Nocardia asteroides into three established species and two unnamed taxons.

Authors:  Andreas Roth; Sebastian Andrees; Reiner M Kroppenstedt; Dag Harmsen; Harald Mauch
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

7.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

Review 8.  Nocardiosis of the central nervous system: experience from a general hospital and review of 84 cases from the literature.

Authors:  Theodora Anagnostou; Marios Arvanitis; Themistoklis K Kourkoumpetis; Athanasios Desalermos; Herman A Carneiro; Eleftherios Mylonakis
Journal:  Medicine (Baltimore)       Date:  2014-01       Impact factor: 1.889

9.  First Report of Nocardia asiatica Presenting as an Anterior Mediastinal Mass in a Patient with Myasthenia Gravis: A Case Report and Review of the Literature.

Authors:  Rima I El-Herte; Souha S Kanj; George F Araj; Hassan Chami; Walid Gharzuddine
Journal:  Case Rep Infect Dis       Date:  2012-07-16

10.  Brain abscess caused by Nocardia asiatica.

Authors:  Atsuhito Uneda; Kenta Suzuki; Shuichi Okubo; Koji Hirashita; Masatoshi Yunoki; Kimihiro Yoshino
Journal:  Surg Neurol Int       Date:  2016-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.